Research Paper Volume 15, Issue 24 pp 15114—15133

Long non-coding RNA signature for predicting gastric cancer survival based on genomic instability

class="figure-viewer-img"

Figure 10. (A) Chemotherapy drugs with differential IC50 expression in the high-risk and low-risk groups predicted by the Prophetic package, and drugs with low IC50 expression in the high risk group were screened out (* * p < 0.01, ***p < 0.001). (B) The drugs predicted by DREMIT website are different in the high and low risk groups, in which the best candidates in the first and second quadrants mean the candidates with more reliable results, while the remaining drugs mean better candidates. (C) Classification of predicted chemotherapeutic drug validation levels. (D) Drug classification of predicted chemotherapeutic agents.